Free Consultation 215.567.2010

Boehringer et al. v. InvaGen (10/25/18 D.NJ) represented generic in ANDA litigation successfully invalidating asserted patents covering Tradjenta® (linagliptin) and Jentadueto® (linagliption and metformin)

Posted on Jul 17, 2019 in

Philadelphia

1635 Market Street, 12th Floor
Philadelphia, Pennsylvania 19103-2212

215-567-2010 | 215-751-1142

View Map

Lehigh Valley

6081 Hamilton Blvd Suite 600
Allentown, Pennsylvania 18106

610-255-7551 | 610-255-7542

View Map